Both in Pharmaceuticals
UroGen Pharma vs Eton Pharmaceutcials
Over the past year URGN returned +45.1% and ETON returned +174.9%; their daily moves had a correlation of 0.08.
URGN +45.1% ETON +174.9%Growth of $1, one year, split-adjusted
| Metric | URGN | ETON |
|---|---|---|
| Price | $28.74 | $50.72 |
| Market cap | $1.40B | $1.45B |
| Today | −16.45% | −0.45% |
| 1 month | −30.6% | −7.4% |
| 6 months | +9.5% | +68.2% |
| Year to date | +22.7% | +199.9% |
| 1 year | +39.4% | +182.4% |
| Revenue growth (YoY) | +199.2% | +98.6% |
| Gross margin | 90.9% | 67.6% |
| Net margin | −19.8% | 30.8% |
| P/E (TTM) | — | 114.3× |
| Price / sales | 7.4× | 13.7× |
| Net cash | -$85.1M | -$1.1M |
| Dividend yield | — | — |
| Volatility (60d) | 54.9% | 89.7% |
| Short % of float | 12.3% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).